Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A W Kinkel

Showing results (11-20 of 23) with videos related to

Pageof 3
Sort By:
Clinical Pharmacology and Therapeutics|May 1, 1980
Plasma levels and urinary excretion of vidarabine after repeated dosingR A Buchanan, A W Kinkel, C A Alford, et al.
Neurology|February 1, 1972
The metabolism of diphenylhydantoin (Dilantin) following once-daily administrationR A Buchanan, A W Kinkel, J R Goulet, et al.
Clinical Pharmacology and Therapeutics|February 1, 1976
Ethosuximide dosage regimensR A Buchanan, A W Kinkel, J L Turner, et al.
Biopharmaceutics & Drug Disposition|January 1, 1989
Bioavailability of propranolol hydrochloride tablet formulations: application of multiple dose crossover studiesM A Eldon, A W Kinkel, J E Daniel, et al.
European Journal of Clinical Pharmacology|January 1, 1986
Comparative single dose and steady-state pharmacokinetics of bevantolol in young and elderly subjectsA Selen, A W Kinkel, A C Darke, et al.
Journal of Clinical Pharmacology|April 1, 1987
The influence of food on the oral absorption of bevantololR D Toothaker, E J Randinitis, C Nelson, et al.
Clinical Pharmacology and Therapeutics|October 1, 1974
Pyrvinium pamoateR A Buchanan, W B Barrow, J C Heffelfinger, et al.
Biopharmaceutics & Drug Disposition|January 1, 1990
A single and multiple dose pharmacokinetic and metabolism study of meclofenamate sodiumJ R Koup, E Tucker, D J Thomas, et al.
The Journal of Antimicrobial Chemotherapy|February 1, 1988
The effect of renal impairment and haemodialysis on single dose pharmacokinetics of oral enoxacinD E Nix, R W Schultz, R W Frost, et al.
Clinical Pharmacology and Therapeutics|October 1, 1975
Bioavailability and single-dose pharmacokinetics of intramuscular phenytoinH B Kostenbauder, R P Rapp, J P McGovren, et al.
Pageof 3

Showing results (11-20 of 23) with videos related to

Sort By:
Pageof 3
Clinical Pharmacology and Therapeutics|May 1, 1980
Plasma levels and urinary excretion of vidarabine after repeated dosingR A Buchanan, A W Kinkel, C A Alford, et al.
Neurology|February 1, 1972
The metabolism of diphenylhydantoin (Dilantin) following once-daily administrationR A Buchanan, A W Kinkel, J R Goulet, et al.
Clinical Pharmacology and Therapeutics|February 1, 1976
Ethosuximide dosage regimensR A Buchanan, A W Kinkel, J L Turner, et al.
Biopharmaceutics & Drug Disposition|January 1, 1989
Bioavailability of propranolol hydrochloride tablet formulations: application of multiple dose crossover studiesM A Eldon, A W Kinkel, J E Daniel, et al.
European Journal of Clinical Pharmacology|January 1, 1986
Comparative single dose and steady-state pharmacokinetics of bevantolol in young and elderly subjectsA Selen, A W Kinkel, A C Darke, et al.
Journal of Clinical Pharmacology|April 1, 1987
The influence of food on the oral absorption of bevantololR D Toothaker, E J Randinitis, C Nelson, et al.
Clinical Pharmacology and Therapeutics|October 1, 1974
Pyrvinium pamoateR A Buchanan, W B Barrow, J C Heffelfinger, et al.
Biopharmaceutics & Drug Disposition|January 1, 1990
A single and multiple dose pharmacokinetic and metabolism study of meclofenamate sodiumJ R Koup, E Tucker, D J Thomas, et al.
The Journal of Antimicrobial Chemotherapy|February 1, 1988
The effect of renal impairment and haemodialysis on single dose pharmacokinetics of oral enoxacinD E Nix, R W Schultz, R W Frost, et al.
Clinical Pharmacology and Therapeutics|October 1, 1975
Bioavailability and single-dose pharmacokinetics of intramuscular phenytoinH B Kostenbauder, R P Rapp, J P McGovren, et al.
Pageof 3